NEW YORK (GenomeWeb News) – Decode Genetics shares were up nearly 11 percent in mid-afternoon trading to $.61 each, following the company's publication yesterday in the advance, online edition of Nature Genetics, reporting that it has identified four new genetic variants associated with prostate cancer risk.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.